{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:31:18Z","timestamp":1787765478073,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["GF21H030024"],"award-info":[{"award-number":["GF21H030024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the general scientific research project of Zhejiang Provincial Department of Education","award":["Y202146219"],"award-info":[{"award-number":["Y202146219"]}]},{"name":"the Postgraduate Education Research Project of Zhejiang University","award":["20220326"],"award-info":[{"award-number":["20220326"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12029-024-01075-x","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T04:02:11Z","timestamp":1723608131000},"page":"1520-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Intrahepatic Mesothelioma: Case Series and Systematic Review of Literature"],"prefix":"10.1007","volume":"55","author":[{"given":"Junjun","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"issue":"5","key":"1075_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.21037\/tlcr.2018.10.04","volume":"7","author":"G Broeckx","year":"2018","unstructured":"Broeckx G, Pauwels P. Malignant peritoneal mesothelioma: a review. Transl Lung Cancer Res. 2018;7(5):537\u201342. https:\/\/doi.org\/10.21037\/tlcr.2018.10.04.","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"1075_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3892\/ol.2013.1461","volume":"6","author":"N Inagaki","year":"2013","unstructured":"Inagaki N, Kibata K, Tamaki T, et al. Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: a case report and review of the literature. Oncol Lett. 2013;6(3):676\u201380. https:\/\/doi.org\/10.3892\/ol.2013.1461.","journal-title":"Oncol Lett"},{"issue":"12","key":"1075_CR3","doi-asserted-by":"publisher","first-page":"002128","DOI":"10.12890\/2020_002128","volume":"7","author":"S Ghimire","year":"2020","unstructured":"Ghimire S, Regmi N, Yang T, et al. Primary malignant mesothelioma of the liver: Case Report and Review of the literature. Eur J Case Rep Intern Med. 2020;7(12):002128. https:\/\/doi.org\/10.12890\/2020_002128.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"5","key":"1075_CR4","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/1097-0142(19890901)64:5<1096::aid-cncr2820640521>3.0.co;2-0","volume":"64","author":"K Kottke-Marchant","year":"1989","unstructured":"Kottke-Marchant K, Hart WR, Broughan T. Localized fibrous tumor (localized fibrous mesothelioma) of the liver. Cancer. 1989;64(5):1096\u2013102. https:\/\/doi.org\/10.1002\/1097-0142(19890901)64:5<1096::aid-cncr2820640521>3.0.co;2-0.","journal-title":"Cancer"},{"issue":"11","key":"1075_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1034\/j.1600-0463.2002.t01-1-1101102.x","volume":"110","author":"J Imura","year":"2002","unstructured":"Imura J, Ichikawa K, Takeda J, et al. Localized malignant mesothelioma of the epithelial type occurring as a primary hepatic neoplasm: a case report with review of the literature. APMIS. 2002;110(11):789\u201394. https:\/\/doi.org\/10.1034\/j.1600-0463.2002.t01-1-1101102.x.","journal-title":"APMIS"},{"issue":"9","key":"1075_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s0730-725x(03)00197-8","volume":"21","author":"P Leonardou","year":"2003","unstructured":"Leonardou P, Semelka RC, Kanematsu M, et al. Primary malignant mesothelioma of the liver: MR imaging findings. Magn Reson Imaging. 2003;21(9):1091\u20133. https:\/\/doi.org\/10.1016\/s0730-725x(03)00197-8.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"1075_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/106689690401200116","volume":"12","author":"A Di Blasi","year":"2004","unstructured":"Di Blasi A, Boscaino A, De Dominicis G, et al. Multicystic mesothelioma of the liver with secondary involvement of peritoneum and inguinal region. Int J Surg Pathol. 2004;12(1):87\u201391. https:\/\/doi.org\/10.1177\/106689690401200116.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"1075_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00428-006-0175-8","volume":"448","author":"I G\u00fctgemann","year":"2006","unstructured":"G\u00fctgemann I, Standop J, Fischer HP. Primary intrahepatic malignant mesothelioma of epithelioid type. Virchows Arch. 2006;448(5):655\u20138. https:\/\/doi.org\/10.1007\/s00428-006-0175-8.","journal-title":"Virchows Arch"},{"issue":"84","key":"1075_CR9","first-page":"1081","volume":"55","author":"DS Kim","year":"2008","unstructured":"Kim DS, Lee SG, Jun SY, et al. Primary malignant mesothelioma developed in liver. Hepatogastroenterology. 2008;55(84):1081\u20134.","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"1075_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3748\/wjg.15.615","volume":"15","author":"M Sasaki","year":"2009","unstructured":"Sasaki M, Araki I, Yasui T, et al. Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis. World J Gastroenterol. 2009;15(5):615\u201321. https:\/\/doi.org\/10.3748\/wjg.15.615.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1075_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/RLU.0b013e31828da61d","volume":"39","author":"A Dong","year":"2014","unstructured":"Dong A, Dong H, Zuo C. Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET\/CT. Clin Nucl Med. 2014;39(7):619\u201322. https:\/\/doi.org\/10.1097\/RLU.0b013e31828da61d.","journal-title":"Clin Nucl Med"},{"issue":"12","key":"1075_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.ijscr.2014.11.028","volume":"5","author":"I Perysinakis","year":"2014","unstructured":"Perysinakis I, Nixon AM, Spyridakis I, et al. Primary intrahepatic malignant epithelioid mesothelioma. Int J Surg Case Rep. 2014;5(12):1098\u2013101. https:\/\/doi.org\/10.1016\/j.ijscr.2014.11.028.","journal-title":"Int J Surg Case Rep"},{"issue":"2","key":"1075_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11604-014-0379-9","volume":"33","author":"A Serter","year":"2015","unstructured":"Serter A, Buyukpinarbasili N, Karatepe O, et al. An unusual liver mass: primary malignant mesothelioma of the liver: CT and MRI findings and literature review. Jpn J Radiol. 2015;33(2):102\u20136. https:\/\/doi.org\/10.1007\/s11604-014-0379-9.","journal-title":"Jpn J Radiol"},{"key":"1075_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijscr.2016.11.001","volume":"30","author":"R Haji Ali","year":"2017","unstructured":"Haji Ali R, Khalife M, El Nounou G, et al. Giant primary malignant mesothelioma of the liver: a case report. Int J Surg Case Rep. 2017;30:58\u201361. https:\/\/doi.org\/10.1016\/j.ijscr.2016.11.001.","journal-title":"Int J Surg Case Rep"},{"key":"1075_CR15","doi-asserted-by":"publisher","first-page":"6242149","DOI":"10.1155\/2016\/6242149","volume":"2016","author":"SS Su","year":"2016","unstructured":"Su SS, Zheng GQ, Liu YG, et al. Malignant peritoneum mesothelioma with hepatic involvement: A single institution experience in 5 patients and review of the literature. Gastroenterol Res Pract. 2016;2016:6242149. https:\/\/doi.org\/10.1155\/2016\/6242149.","journal-title":"Gastroenterol Res Pract"},{"key":"1075_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40792-017-0342-y","volume":"3","author":"K Minami","year":"2017","unstructured":"Minami K, Okumura H, Hiwatashi K, et al. Multiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literature. Surg Case Rep. 2017;3:66. https:\/\/doi.org\/10.1186\/s40792-017-0342-y.","journal-title":"Surg Case Rep"},{"issue":"2","key":"1075_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5582\/irdr.2018.01052","volume":"7","author":"D Zhou","year":"2018","unstructured":"Zhou D, Quan Z, Wang J. Current status of malignant mesothelioma with liver involvement in China: a brief report and review of the literature. Intractable Rare Dis Res. 2018;7(2):112\u20139. https:\/\/doi.org\/10.5582\/irdr.2018.01052.","journal-title":"Intractable Rare Dis Res"},{"issue":"15","key":"1075_CR18","doi-asserted-by":"publisher","first-page":"e15147","DOI":"10.1097\/MD.0000000000015147","volume":"98","author":"WJ Huang","year":"2019","unstructured":"Huang WJ, Li ZH, Wang Z, et al. Primary malignant mesothelioma of the diaphragm with liver invasion: a case report and review of literature. Med (Baltim). 2019;98(15):e15147. https:\/\/doi.org\/10.1097\/MD.0000000000015147.","journal-title":"Med (Baltim)"},{"key":"1075_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijscr.2018.04.004","volume":"47","author":"H Ismael","year":"2018","unstructured":"Ismael H, Cox S. Primary intrahepatic mesotheliomas: a case presentation and literature review. Int J Surg Case Rep. 2018;47:1\u20136. https:\/\/doi.org\/10.1016\/j.ijscr.2018.04.004.","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"1075_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13256-019-2008","volume":"13","author":"T Miyata","year":"2019","unstructured":"Miyata T, Fujiwara Y, Nishijima K, et al. Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report. J Med Case Rep. 2019;13(1):66. https:\/\/doi.org\/10.1186\/s13256-019-2008. Asian 9.","journal-title":"J Med Case Rep"},{"issue":"11","key":"1075_CR21","doi-asserted-by":"publisher","first-page":"e237721","DOI":"10.1136\/bcr-2020-237721","volume":"13","author":"T Tanaka","year":"2020","unstructured":"Tanaka T, Miyamoto Y, Sakai A, et al. Nivolumab for malignant peritoneal mesothelioma. BMJ Case Rep. 2020;13(11):e237721. https:\/\/doi.org\/10.1136\/bcr-2020-237721.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"1075_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/RLU.0000000000004445","volume":"48","author":"B Pernthaler","year":"2023","unstructured":"Pernthaler B, Brcic L, Aigner RM, et al. 18F-FDG PET\/CT in primary mesothelioma of the liver. Clin Nucl Med. 2023;48(1):49\u201351. https:\/\/doi.org\/10.1097\/RLU.0000000000004445.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"1075_CR23","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1016\/j.asjsur.2023.04.052","volume":"46","author":"C Wei","year":"2023","unstructured":"Wei C, Sun W, Cui M, et al. Primary sarcomatoid malignant mesothelioma of the liver: A case report. J Surg. 2023;46(9):4058\u20139. https:\/\/doi.org\/10.1016\/j.asjsur.2023.04.052.","journal-title":"J Surg"},{"issue":"7","key":"1075_CR24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3390\/jcm11071891","volume":"11","author":"RT Tandon","year":"2022","unstructured":"Tandon RT, Jimenez-Cortez Y, Taub R, et al. Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases. Arch Pathol Lab Med. 2022;11(7):1891. https:\/\/doi.org\/10.3390\/jcm11071891.","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"1075_CR25","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3390\/jcm11071891","volume":"11","author":"CY Li","year":"2022","unstructured":"Li CY, Kennedy T, Alexander HR. Treatment of Patients with Malignant Peritoneal Mesothelioma. J Clin Med. 2022;11(7):1891. https:\/\/doi.org\/10.3390\/jcm11071891.","journal-title":"J Clin Med"},{"issue":"2","key":"1075_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41379-019-0352-3","volume":"33","author":"AM Marchevsky","year":"2020","unstructured":"Marchevsky AM, Khoor A, Walts AE, et al. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel. Mod Pathol. 2020;33(2):281\u201396. https:\/\/doi.org\/10.1038\/s41379-019-0352-3.","journal-title":"Mod Pathol"},{"issue":"10","key":"1075_CR27","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-16-0229","volume":"15","author":"S Kato","year":"2016","unstructured":"Kato S, Tomson BN, Buys TP, et al. Genomic Landscape of Malignant Mesotheliomas. Mol Cancer Ther. 2016;15(10):2498\u2013507. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0229.","journal-title":"Mol Cancer Ther"},{"issue":"7659","key":"1075_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature22798","volume":"546","author":"A Bononi","year":"2017","unstructured":"Bononi A, Giorgi C, Patergnani S, et al. BAP1 regulates IP3R3-mediated Ca2\u2009+\u2009flux to mitochondria suppressing cell transformation. Nature. 2017;546(7659):549\u201353. https:\/\/doi.org\/10.1038\/nature22798.","journal-title":"Nature"},{"issue":"24","key":"1075_CR29","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","volume":"22","author":"J Fleury-Feith","year":"2003","unstructured":"Fleury-Feith J, Lecomte C, Renier A, et al. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene. 2003;22(24):3799\u2013805. https:\/\/doi.org\/10.1038\/sj.onc.1206593.","journal-title":"Oncogene"},{"key":"1075_CR30","doi-asserted-by":"publisher","first-page":"e007070","DOI":"10.3389\/fonc.2022.836751","volume":"12","author":"FT Tostes","year":"2022","unstructured":"Tostes FT, Zugman M, Paes VR, et al. Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma. Front Oncol. 2022;12:e007070. https:\/\/doi.org\/10.3389\/fonc.2022.836751.","journal-title":"Front Oncol"},{"issue":"8","key":"1075_CR31","doi-asserted-by":"publisher","first-page":"e007070","DOI":"10.1136\/jitc-2023-007070","volume":"11","author":"MV Dietz","year":"2023","unstructured":"Dietz MV, Quintelier KLA, van Kooten JP, et al. Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial. J Immunother Cancer. 2023;11(8):e007070. https:\/\/doi.org\/10.1136\/jitc-2023-007070.","journal-title":"J Immunother Cancer"},{"key":"1075_CR32","doi-asserted-by":"publisher","unstructured":"Ettinger DS, Wood DE, Stevenson J, et al. Mesothelioma: Peritoneal, version 2. NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;(9):961\u2013979. https:\/\/doi.org\/10.6004\/jnccn.2023.0045.","DOI":"10.6004\/jnccn.2023.0045"},{"issue":"10026","key":"1075_CR33","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman G, Mazieres J, Margery J, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet. 2016;387(10026):1405\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(15)01238-6.","journal-title":"Lancet"},{"issue":"7","key":"1075_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jtho.2022.04.008","volume":"17","author":"A Louw","year":"2022","unstructured":"Louw A, Panou V, Szejniuk WM, et al. BAP1 loss by immunohistochemistry predicts Improved Survival to First-Line platinum and Pemetrexed Chemotherapy for patients with Pleural Mesothelioma: a validation study. J Thorac Oncol. 2022;17(7):921\u201330. https:\/\/doi.org\/10.1016\/j.jtho.2022.04.008.","journal-title":"J Thorac Oncol"},{"issue":"11","key":"1075_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947","volume":"21","author":"LM LaFave","year":"2015","unstructured":"LaFave LM, B\u00e9guelin W, Koche R, et al. Loss of BAP1 function leads to EZH2-dependent transformation. Nat Med. 2015;21(11):1344\u20139. https:\/\/doi.org\/10.1038\/nm.3947.","journal-title":"Nat Med"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01075-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-024-01075-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01075-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T15:21:17Z","timestamp":1728487277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-024-01075-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1007\/s12029-024-01075-x","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"26 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (ITT20210921A), and all patients gave their informed consent prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Patient Consent Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}